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We have shown here that the apoptosis inducer stau-
rosporine causes an early decrease in the endogenous
respiration rate in intact 143B.TK cells. On the other
hand, the activity of cytochrome c oxidase is unchanged
for the first 8 h after staurosporine treatment, as deter-
mined by oxygen consumption measurements in intact
cells. The decrease in the endogenous respiration rate
precedes the release of cytochrome c from mitochon-
dria. Moreover, we have ruled out caspases, permeabil-
ity transition, and protein kinase C inhibition as being
responsible for the decrease in respiration rate. Fur-
thermore, overexpression of the gene for Bcl-2 does not
prevent the decrease in respiration rate. The last find-
ing suggests that Bcl-2 acts downstream of the pertur-
bation in respiration. The evidence of normal enzymatic
activities of complex I and complex III in staurosporine-
treated 143B.TK osteosarcoma cells indicates that the
cause of the respiration decrease is probably an alter-
ation in the permeability of the outer mitochondrial
membrane. Presumably, the voltage-dependent anion
channel closes, thereby preventing ADP and oxidizable
substrates from being taken up into mitochondria. This
interpretation was confirmed by another surprising
finding, namely that, in staurosporine-treated 143B.TK
cells permeabilized with digitonin at a concentration
not affecting the mitochondrial membranes in naive
cells, the outer mitochondrial membrane loses its integ-
rity; this leads to a reversal of its impermeability to
exogenous substrates. The loss of outer membrane in-
tegrity leads also to a massive premature release of cy-
tochrome c from mitochondria. Most significantly, Bcl-2
overexpression prevents the staurosporine-induced hy-
persensitivity of the outer membrane to digitonin. Our
experiments have thus revealed early changes in the
outer mitochondrial membrane, which take place long
before cytochrome c is released from mitochondria in
intact cells.
It has become clear over the last several years that mitochon-
dria play a central role in the cell death program initiated by
most inducers of apoptosis. Several key components of the
apoptotic machinery, i.e. cytochrome c, AIF (apoptosis-inducing
factor), SMAC/Diablo, and HtrA2/Omi, are released from mito-
chondria in cells undergoing apoptosis (1–5). Although the
importance of mitochondrial changes leading to the release of
these apoptogenic molecules is well established, the detailed
mechanism(s) involved in this phenomenon, and in particular,
the possible role of dysfunctions of the oxidative phosphoryla-
tion apparatus and of oxidative stress, have yet to be clarified.
The observation that mitochondrial DNA-less (°) cells can be
induced to undergo apoptosis (6, 7) has led to the conclusion
that the apoptotic program does not require a functional oxi-
dative phosphorylation apparatus. However, these experi-
ments did not exclude the possibility that, in normally respir-
ing cells, oxidative phosphorylation alterations do play an
important role in the early phase of apoptosis and that this role
can be bypassed by the profound biochemical changes accom-
panying the establishment of ° cells. Indeed, several mito-
chondrial functional changes, such as impaired mitochondrial
adenine nucleotide exchange (8) and permeability transition
pore (9) opening with membrane potential collapse (10), have
been suggested to play an important role in apoptosis. More-
over, the level of cellular ATP can determine whether a cell
undergoes necrosis or apoptosis (11). We considered the possi-
bility that investigating the respiratory activity in cells induced
to undergo apoptosis might reveal changes in mitochondria
that precede, and may contribute to, the release of cytochrome
c and other apoptogenic molecules. Our investigations on
143B.TK osteosarcoma cells induced to undergo apoptosis
with staurosporine have indeed revealed two early changes in
mitochondria that result from initiation of the apoptosis pro-
gram. These are 1) a decrease in the permeability of the outer
membrane, pointing to a closure of the voltage-dependent an-
ion channel (VDAC),1 and 2) a hypersensitivity of the outer
mitochondrial membrane to digitonin, suggesting that a
change in lipid organization or composition has taken place.
EXPERIMENTAL PROCEDURES
Cell Culture—143B.TK, a human osteosarcoma-derived cell line
(ATCC CRL 8303) (12–15), and hereafter referred to as 143B, was
grown in Dulbecco’s modified Eagle’s medium supplemented with 5 or
10% fetal bovine serum. For induction of apoptosis, semiconfluent
dishes of cells were exposed for different times to 1 M staurosporine.
For experiments involving respiration measurements, cells were plated
3 days before the experiment, and the medium was changed in the
afternoon or evening of the day before.
Bcl-2 Transfection—A human Bcl-2 cDNA (16) was subcloned from
SFFV-Bcl-2 n1 into the neomycin resistance marker-containing plas-
mid pcDEF3 (17) and then used for transfection of 143B cells by calcium
phosphate precipitation (18). Stably transfected clones were selected in
medium containing 0.5 mg/ml G418 sulfate (Geneticin; Invitrogen).
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Nuclear Apoptosis Assay—The cells were grown in a 6-cm Petri dish;
0.5 volume of phosphate-buffered saline (PBS; 0.145 M NaCl, 8.1 mM
Na2HPO4, 1.5 mM KH2PO4, pH 7.65), and formaldehyde, to a final
concentration of 4%, was added directly to the medium in the dish. After
10 min at room temperature, bovine serum albumin was added to 0.1%,
and the cells were collected by scraping them with a rubber policeman
and then transferred into a centrifuge tube. The cells were washed once
with PBS, 0.1% bovine serum albumin and then resuspended in 1 ml of
the same solution and stained with 1 g/ml of the double-stranded
DNA-binding fluorochrome 4,6-diamidino-2-phenylindole (DAPI) for 10
min at room temperature, with occasional agitation. The cells were
collected by centrifugation, resuspended in 10 l of PBS, mixed with 10
l of a 50:50 mixture of glycerol and 2 PBS, and mounted on a slide for
viewing in a fluorescence microscope.
Oxygen Consumption Measurements in Intact Cells—The respiration
rate was measured in an oxygraph (Yellow Springs Instruments, model
5300) in a suspension of naive or staurosporine-treated cells at 3–6 
106 cells/ml in TD buffer (25 mM Tris-HCl, pH 7.4–7.5 (25 °C), 137 mM
NaCl, 10 mM KCl, 0.7 mM Na2HPO4) at 37 °C. Previous work from this
laboratory had shown that 143B cells respire in TD buffer at the same
rate as in Dulbecco’s modified Eagle’s medium lacking glucose (19).
After obtaining a stable rate, the uncoupler dinitrophenol (DNP) was
added at a concentration of 17–25 M, and the resulting respiration rate
was recorded. After blocking the electron flux upstream of cytochrome
c oxidase with 20 nM antimycin A, the cytochrome c oxidase-dependent
oxygen consumption rate isolated from the upstream segment of the
respiratory chain was measured by using the membrane-permeant
electron donor N,N,N,N-tetramethyl-p-phenylenediamine (TMPD) at
400 M and ascorbate, as primary reducing agent, at 10 mM (19). The
rate of TMPD-driven O2 consumption was corrected for the autooxida-
tion rate of TMPD, measured on the same day, as determined in a
separate run in TD in the absence of cells. Oxygen consumption rates
were expressed in nmol of oxygen consumed/min/mg of cellular protein.
The rates of the treated samples were calculated as percentages of the
rates of untreated samples, determined on the same day.
Oxygen Consumption Measurements in Digitonin-permeabilized
Cells—Digitonin permeabilization was carried out by a modification of
a previously described procedure (20–22). For measurements of gluta-
mate/malate- and succinate-driven respiration rates, 2–10  106 cells
were harvested by trypsinization, washed in 5 ml of Respiration Buffer
I (modified from Ref. 23: 30 mM HEPES, pH 7.1, 75 mM sucrose, 20 mM
glucose, 5 mM potassium Pi, 40 mM KCl, 0.5 mM EDTA, 3 mM MgCl2),
centrifuged, and resuspended in 0.15 ml of the same buffer per 106 cells.
A fresh 1000-fold dilution of 10% (w/v) digitonin was then made in
Respiration Buffer I, an equal volume of the 0.01% digitonin was added
to the cell suspension, and the mixture was incubated for 2 min at room
temperature. A concentration of 0.005% digitonin permeabilized, in
general, 100% of untreated 143B cells and 97–100% of cells treated with
staurosporine. Permeabilization was stopped by the addition of 8–10
volumes of Respiration Buffer I containing 0.3% bovine serum albumin.
After confirming by trypan blue uptake that at least 95% of the cells
were permeabilized, the cells were centrifuged, resuspended in 150 or
300 l of Respiration Buffer I, and transferred into one or two oxygraph
chambers, respectively, each containing about 1.4 ml of the same buffer.
Respiration measurements were carried out in the presence of 1 mM
ADP. Glutamate and malate were added at 5 mM each. Alternatively,
40–200 nM rotenone and 10 mM succinate were added. Both the coupled
and 17–25 M DNP-uncoupled rates were determined. Cytochrome c,
when used, was 115 M. To measure TMPD-driven rates, permeabili-
zation was carried out, and respiration rates, measured in an alterna-
tive buffer, Respiration Buffer II (0.25 M sucrose, 20 mM Hepes-KOH,
pH 7.1, 2 mM potassium phosphate, 10 mM MgCl2, 1 mM ADP (20))
because the autooxidation rate of TMPD is lower in Respiration Buffer
II than in Respiration Buffer I. For these measurements, 20 nM anti-
mycin, 0.4 mM TMPD, and 10 mM ascorbate were used. The TMPD-de-
pendent respiration rate was determined after subtraction of the au-
tooxidation rate, measured on the same day. Respiration rates were
expressed as nmol/min/mg. Rates of treated samples were compared
with those of untreated samples determined on the same day.
In one experiment aimed at testing the possibility of transactivation
(from cell to cell), the cells were suspended at one-seventieth of the
usual concentration during permeabilization. Because of the high dilu-
tion, 10 times as much digitonin per cell (but only one-seventh the usual
concentration) had to be used to effect permeabilization of the plasma
membrane. After 2 min of incubation at room temperature and the
addition of bovine serum albumin to quench the action of the digitonin,
the cells were centrifuged, resuspended, and added to the oxygraph
chamber.
Confocal Immunofluorescence Microscopy—Cells grown on coverslips
were fixed and stained for immunofluorescence as detailed (24). In
brief, the cells were double-labeled with mouse anti-cytochrome c mono-
clonal antibody 6H2.B4 (Pharmingen) and rabbit anti-Hsp60 antiserum
(Stressgen Biotechnologies Corp.). The secondary antibodies were flu-
orescein isothiocyanate-conjugated goat anti-mouse IgG and lyssamine-
rhodamine-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch
Laboratories). The preparations were analyzed on a Zeiss 310 laser
scanning confocal microscope. In some experiments, the cells were
centrifuged onto glass coverslips and then fixed and treated as de-
scribed above. Cells with punctate cytochrome c staining (green) that
overlapped with Hsp60 staining (red) were counted as cells with mito-
chondrial cytochrome c staining, whereas cells with diffuse nuclear and
cytosolic cytochrome c staining and punctate mitochondrial Hsp60
staining were counted as cells with extramitochondrial cytochrome c.
Preparation of Mitochondrial Fraction—Cells were harvested from
40 T-175 flasks by trypsinization and washed thrice in PBS. For cell
breakage, the cells were resuspended in mitochondria isolation medium
consisting of 0.25 M sucrose, 10 mM Hepes-KOH, pH 7.4, 1 mM EGTA,
and 0.5% bovine serum albumin. The cells were disrupted with a
motor-driven Potter-Elvehjem glass-Teflon homogenizer until 80% of
the nuclei had been released. The mitochondrial fraction was isolated
by differential centrifugation (25) and subsequently washed and resus-
pended in mitochondria isolation medium and stored at 80°.
Enzyme Activity Assays—All assays were carried out at room tem-
perature in a split-beam spectrophotometer. The mitochondria-en-
riched fraction was thawed, adjusted to a mitochondrial protein con-
centration of 1 mg/ml, and frozen and thawed two more times. For
assays of complex I, complex III, and complex I  III activities, the
mitochondria were sonicated in a microcentrifuge tube, immersed in ice
water, with a stepped microtip using a Branson Digital Sonifier for 60 s
in 2-s bursts at 8-s intervals at 20% amplitude. The output was 3 watts.
Complex I activity was assayed in samples containing 30 g of
mitochondrial protein in 50 mM potassium phosphate, pH 7.5, 2 mM
KCN, 50 M NADH. The reaction was started by the addition of 10 M
decylubiquinone, and the change in absorbance at 340 nm was re-
corded. For both complex III and complex I–III activity measurements,
the assay mixtures were as described (26), and the increase in absorb-
ance at 550 nm was recorded.
Cytochrome c oxidase activity was measured at 550 nm in samples
containing 10 g of mitochondrial protein, using unsonicated mitochon-
dria, in 40 mM potassium phosphate, pH 6.65, with 0.5% Tween 80 (low
peroxide, Sigma) in the cuvette. The initial concentration of reduced
cytochrome c was 0.04% w/v. The aforementioned assays measured
inhibitor-sensitive activities as the reference cuvette in the split beam
spectrophotometer contained the reaction mixture plus inhibitor. The
inhibitors for complex I, complex III, complex I–III, and cytochrome c
oxidase activity assays were 2 M rotenone, 5 g/ml antimycin, 5 g/ml
antimycin, and 1 mM KCN, respectively.
Citrate synthase activity was measured in unsonicated mitochondria
by using buffer and reagent concentrations as described (26). In addi-
tion, the cuvette contained 0.5% Triton X-100 to lyse the mitochondria.
The change in absorbance at 412 nm was recorded. The reference
cuvette contained the reaction mixture lacking oxaloacetate.
Reagents—Benzyloxycarbonyl-Val-Ala-Asp fluoromethyl ketone
(zVADfmk) was purchased from Kamiya Biomedicals; bisindolylmale-
imide GF 109203X (Bis-I) (27, 28) was purchased from Calbiochem.
Cyclosporine A (CsA) was a gift from Sandoz Research Institute, East
Hanover, NJ. All other reagents were obtained from Sigma.
Miscellaneous—Protein concentration was determined as described
(29).
RESULTS
Early Decrease in Endogenous Respiration Rate in Stauro-
sporine-treated 143B Cells—143B osteosarcoma cells induced
to undergo apoptosis by exposure to 1 M staurosporine exhib-
ited a rapid decline in their respiration rate in the first hour, to
80% of the normal rate, followed by a slower decline over the
next 15 h, to 35% of normal (Fig. 1). This rate was measured in
intact cells suspended in buffered saline solution. Thus, respi-
ration in these cells was driven by endogenous substrates. The
rate of respiration uncoupled by the addition of DNP decreased
with staurosporine exposure in a way that paralleled closely
the decrease in endogenous respiration. To measure the respi-
ratory activity of the terminal enzyme of the respiratory chain,
cytochrome c oxidase, the upstream segment of the respiratory
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chain was first blocked by the addition of antimycin. Respira-
tion was then started by the addition of a cell-permeant reduc-
tant of cytochrome c, TMPD, and the primary reductant, ascor-
bate. The TMPD-driven respiration rate, which was typically
1.4–1.7 times higher than the endogenous substrate-depend-
ent rate, was minimally affected (5%) during the first 6 h of
staurosporine treatment and then slowly declined to about 70%
of the control rate by 16 h of cell exposure to the drug.
The Decrease in Respiration Rate Precedes Cytochrome c
Release—Cytochrome c was released from mitochondria in cells
treated with staurosporine, as shown in Fig. 2. The anti-cyto-
chrome c antibodies revealed a diffuse extramitochondrial lo-
calization of cytochrome c in a progressively increasing fraction
of the cells during their treatment with the drug, whereas in all
untreated cells, cytochrome c had a punctate distribution and
co-localized with Hsp60, a mitochondrial protein. It appears
from Fig. 2 that in many cells, the extramitochondrial cyto-
chrome c had a nuclear localization. This phenomenon was
reported previously in breast carcinoma cells induced to apo-
ptosis by tumor necrosis factor- or staurosporine (30) and in
NIH-3T3 cells induced to apoptosis by actinomycin D (31), and
it was observed in PC12 cells treated with staurosporine.2 The
proportion of cells that showed release of cytochrome c was
quantified at various times after staurosporine addition. Fig. 1
shows that the percentage of cells having released cytochrome
c was less than the percentage of decrease in endogenous res-
piration rate for the first 6 h after staurosporine addition,
indicating that the respiration decrease was not dependent on
cytochrome c release from mitochondria. Furthermore, the
fraction of cells that had reached the late apoptosis stage of
nuclear fragmentation was determined in DAPI-stained cells
(Fig. 1). Under the reasonable assumption that the fraction of
cells having released cytochrome c included those undergoing
nuclear fragmentation, it appears that cells reached this stage
only 2–3 h after their mitochondria had released cytochrome c.
For the first 8 h after staurosporine addition to 143B cells,
the TMPD-driven respiration rate did not decrease signifi-
cantly (Fig. 1), indicating that cytochrome c oxidase activity
remained high. On the other hand, by 8 h after staurosporine
addition, mitochondria had already massively released cyto-
chrome c in 40% of 143B cells. This fact indicated that, even
after cytochrome c had been released, the level of cytochrome c
available to cytochrome c oxidase was still sufficient to main-
tain normal cytochrome c oxidase activity. This is consistent
with the finding of Waterhouse et al. (32) that the mitochon-
drial membrane potential could be maintained by respiration
after cytochrome c release (provided that caspase activity was
inhibited).
Tests of Possible Role of Caspases, Permeability Transition,
and Protein Kinase Inhibition in Respiration Decrease—To
gain some insight into the mechanisms underlying the de-
crease in endogenous respiration rate in staurosporine-treated
cells, several inhibitors were tested for the ability to modify
this effect of staurosporine. The caspase inhibitor zVADfmk
failed to prevent the decrease in respiration rate (Fig. 3a) and,
as had been found previously (33), the release of cytochrome c
from mitochondria (Fig. 2), whereas apoptosis was completely
inhibited in these cells (not shown). Thus, it appeared that the
respiration decrease was not dependent on the activity of
caspases. An inhibitor of the permeability transition, CsA (34–
36), present at 10 mM during the staurosporine treatment, also
had no significant effect on the decrease in respiration (Fig. 3b).2 E. Ferraro and G. Attardi, personal communication.
FIG. 1. Decrease in endogenous respiration rate precedes cy-
tochrome c release in intact staurosporine-treated 143B cells.
Respiration rates of intact 143B cells treated with 1 M staurosporine
for different lengths of time were measured as described under “Exper-
imental Procedures” and normalized to the protein content of the sam-
ples. Values (averages of 2–11 independent experiments  one stand-
ard deviation) are given as percentages of the rates in untreated cells
measured on the same day. (Filled squares, endogenous substrate-de-
pendent respiration; open squares, uncoupled endogenous substrate-de-
pendent respiration; filled circles, TMPD-driven respiration.) The in-
crease with time of the percentage of cells having released cytochrome
c from mitochondria after staurosporine addition was determined by
confocal laser scanning microscopy (filled triangles, percentage of cells
with extramitochondrial cytochrome c). In other experiments, cells
stained with DAPI were viewed by fluorescence microscopy, and total
cells and cells with fragmented nuclei were counted in several adjacent
fields (open diamonds, percentage of cells with fragmented nuclei).
FIG. 2. Distribution of cytochrome c in intact staurosporine-
treated and untreated cells and B15 Bcl-2-overexpressing cells.
Untreated 143B and Bcl-2-overexpressing 143B cells (B15) and the
same cells exposed to staurosporine (sts) for 8 h were fixed and double-
immunolabeled with antibodies directed against cytochrome c and
against Hsp60. The panels in the third column show the merged images
of green (cytochrome c) and red (Hsp60) fluorescence. In one experi-
ment, 143B cells were exposed to zVADfmk during the staurosporine
treatment.
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Treatment of the cells with 20 mM CsA for 6 h or with 10 mM
CsA added twice during the staurosporine treatment likewise
had no effect (not shown). These results indicated that, barring
an unusual failure of the cells to take up the drug or a high
capacity to export it, permeability transition did not influence
the decrease in respiration rate.
Lastly, an attempt was made to dissociate the respiration
rate decline from the apoptotic program. Specifically, we used
an analog of staurosporine, Bis-I (27, 28), which, like stauro-
sporine, inhibits protein kinase C (28, 37), but unlike stauro-
sporine, does not induce apoptosis (37). Fig. 3c shows that 1 M
Bis-I did not cause a decrease in respiration rate. It was also
confirmed that Bis-I did not induce apoptosis in 143B cells
(data not shown). Thus, these experiments did not provide any
evidence that the respiration decline is not a part of the apo-
ptotic program.
Bcl-2-overexpressing 143B Cells Also Exhibit the Early En-
dogenous Respiration Decrease—Experiments were carried out
to determine whether overexpression of the antiapoptotic pro-
tein Bcl-2 (16) would prevent the decrease in respiration rate.
143B cells were stably transfected with a cDNA clone for Bcl-2,
and an overexpressing clone, B15, was analyzed for its re-
sponse to staurosporine. As observed previously for Bcl-2-over-
expressing staurosporine-treated HL-60 cells (38), Bcl-2-over-
expressing 143B cells did not release cytochrome c from
mitochondria upon exposure to staurosporine (Fig. 2). Also, as
expected, the cells did not undergo apoptosis, as assayed by
nuclear fragmentation (Fig. 4). Nevertheless, as Fig. 4 shows,
B15 cells exhibited a decrease in both coupled and uncoupled
respiration rates of a degree comparable with that observed in
143B cells. Thus, it appeared that the site of Bcl-2 activity was
downstream of the respiration rate decrease or in an independ-
ent pathway.
Hypersensitivity of the Outer Mitochondrial Membrane to
Digitonin is an Early Staurosporine-induced Effect—The en-
dogenous substrate-dependent respiration rate depends on
three other respiratory chain complexes besides complex IV:
namely, complex I, or respiratory NADH dehydrogenase; com-
plex III, or ubiquinone-cytochrome c oxidoreductase; and com-
plex II, or succinate dehydrogenase. Electrons pass from
NADH, generated by the oxidation of metabolites, sequentially
to complex I, ubiquinone, complex III, cytochrome c, complex
IV, and finally, oxygen. Electrons from fatty acid oxidation can
also enter the respiratory chain via succinate and succinate
dehydrogenase. This enzyme transfers electrons to ubiquinone,
and subsequently, electron transfer continues as described
above. In 143B cells, the endogenous substrate-dependent res-
piration has been found to be 90% inhibitable by rotenone, an
inhibitor of complex I (not shown); thus, electrons from endog-
enous substrates enter the chain almost exclusively through
complex I, and very few electrons enter through complex II.
Therefore, the observed early decrease in respiration rate in
staurosporine-treated cells could be due to a decrease in either
complex I or complex III activity or both.
By using digitonin-permeabilized cells and by providing mi-
tochondria with exogenous substrates that feed into complex I
or that bypass complex I, one can determine which respiratory
enzyme activity is decreased. Fig. 5a shows the results of
exogenous substrate-driven respiration assays performed on
digitonin-permeabilized 143B cells. Surprisingly, all activities,
whether driven by glutamate and malate (electrons entering
the respiratory chain at complex I), succinate (electrons enter-
ing at complex II), or TMPD and ascorbate (electrons entering
at complex IV), were reduced by at least 75% within 4 h after
staurosporine addition. The relative rates shown in Fig. 5a
represent the initial rates after the addition of DNP. For each
substrate, the respiration rate decreased, in staurosporine-
treated cells, during the measurement, over the course of min-
utes. The difference observed between the dramatic decreases
in respiration rates in permeabilized cells and the moderate
decreases in intact cells suggested the possibility that digitonin
treatment had removed an electron carrier or some other com-
ponent(s) of the respiratory chain in cells treated with stauro-
sporine. The addition to the oxygraph chamber of 10 M ubiqui-
none (oxidized or reduced) had no effect (not shown). On the
contrary, the addition of cytochrome c restored the ability of the
permeabilized staurosporine-treated cells to respire (Fig. 6a),
suggesting that the electron carrier cytochrome c had been lost
from mitochondria. In fact, in the presence of added cytochrome
c, respiration driven by glutamate and malate, by succinate, or
by TMPD/ascorbate attained the rates observed in permeabi-
lized untreated cells. To confirm that digitonin treatment of
staurosporine-treated 143B cells caused the premature loss of
cytochrome c from mitochondria, permeabilized treated and
untreated cells were incubated with anti-cytochrome c and
anti-Hsp60 antibodies and examined by confocal fluorescence
FIG. 3. Staurosporine-induced decline in respiration rate is
not prevented by inhibitors of caspases (zVADfmk) or perme-
ability transition (CsA) or mimicked by protein kinase C inhib-
itor (Bis-I). As shown in a, 100 M zVADfmk (zVAD) was added to
cultures 1 h prior to the addition of 1 M staurosporine. As shown in b,
10 mM CsA was added at the time of staurosporine addition. As shown
in c, 1 M Bis-I instead of staurosporine was added to cultures at time
0. Cultures were harvested and assayed for respiration activity 6 h after
staurosporine (a and b) or Bis-I (c) addition. Black bars represent
endogenous substrate-dependent respiration; stippled bars represent
DNP-uncoupled endogenous substrate-dependent respiration; and
hatched bars represent TMPD-driven respiration. Values are given as
percentages of the rates in untreated cells. Data in panels b and c are
averages of 2 independent experiments  one standard deviation.
FIG. 4. Staurosporine-treated B15 Bcl-2-overexpressing cells
also exhibit the early decline in endogenous respiration rate.
The respiration rates of intact B15 cells treated with 1 M staurosporine
were measured as described under “Experimental Procedures,” normal-
ized to the protein content of the samples, and presented as percentages
of the rates in untreated cells, measured on the same day. Except for the
16 h data, values given are averages of 2–4 independent experiments
one standard deviation. (Filled squares, endogenous substrate-depend-
ent respiration; open squares, uncoupled endogenous substrate-depend-
ent respiration; filled circles, TMPD-driven respiration.) The propor-
tions of cells with extramitochondrial cytochrome c (cyt c) (triangles)
and with fragmented nuclei (diamonds) are indicated as well.
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microscopy. Fig. 7 shows that cytochrome c was virtually ab-
sent in the permeabilized staurosporine-treated cells, but it
was readily visible and co-localized with Hsp60 in the digito-
nin-permeabilized untreated cells.
The most plausible explanation for the loss of cytochrome c
from mitochondria of staurosporine-treated and permeabilized
143B cells was that the mitochondrial outer membrane had lost
integrity. However, an alternative explanation was that the
digitonin permeabilization of the plasma membrane allowed
the diffusion of transactivating factors from cells advanced in
the apoptotic program to cells less advanced. To test this hy-
pothesis, digitonin permeabilization of staurosporine-treated
143B cells was performed at a very low cell concentration, i.e.
at one-seventieth of the normal concentration, to dilute any
possible transactivating factors, thereby presumably reducing
their activity. In this experiment, exogenous substrate-driven
respiration rates were found to be decreased as much as in a
parallel experiment in which permeabilization was carried out
at the usual cell concentration (not shown). This result strongly
suggested that the loss of cytochrome c from mitochondria was
not due to the action of transactivating factors.
Lack of Hypersensitivity to Digitonin in Bcl-2-overexpressing
Staurosporine-treated Cells—Quite different results from those
described above were obtained with B15 Bcl-2-overexpressing
cells treated with staurosporine and permeabilized with digi-
tonin (Fig. 5b). In fact, in B15 cells permeabilized after 6 h of
exposure to staurosporine, the glutamate- and malate-driven
respiration rate was decreased by 40%, and the succinate-
driven rate was decreased by 37% (Fig. 5b). The decrease in the
glutamate/malate-driven respiration rate was thus very simi-
lar to the decrease, 30–35%, which had been observed in the
endogenous substrate-dependent respiration rate of intact B15
and 143B cells. The TMPD-driven respiration rate in the digi-
tonin-permeabilized B15 cells was not decreased by the stau-
rosporine treatment, as had been observed in intact cells. Fur-
thermore, the addition of cytochrome c had no effect on the
glutamate/malate- or succinate-driven respiration rates of
staurosporine-treated permeabilized B15 cells (Fig. 6b). These
results thus led to the conclusion that Bcl-2 protected stauro-
sporine-treated cells from the dramatic loss of cytochrome c
and respiration caused by permeabilization with digitonin.
Thus, presumably, Bcl-2 helped to maintain the integrity of the
outer mitochondrial membrane.
Respiratory Enzyme Defects Are Not Involved in the Early
Endogenous Respiration Decrease—The polarography experi-
ments carried out on B15 cells suggested that both complex I
and complex III activities were affected by staurosporine treat-
ment of the cells (Fig. 5b). To validate this suggestion and to
extend it to 143B cells, spectrophotometric enzyme assays were
performed on disrupted mitochondria from 143B cells treated
FIG. 5. Respiration rates in digitonin-permeabilized 143B and
B15 cells treated with 1 M staurosporine. Respiration measure-
ments were carried out in the presence of DNP. The glutamate/malate-
(squares), succinate- (diamonds), and TMPD/ascorbate- (circles) driven
rates in staurosporine-treated cells were normalized to the protein
content of the samples and expressed as percentages of the rates in
untreated cells. The data presented are averages  one standard devi-
ation of 2–7 independent experiments. a, 143B cells; b, B15 cells.
FIG. 6. Addition of cytochrome c (cyt c) restores respiration in
digitonin-permeabilized 143B cells treated with staurosporine
but not in B15 cells. Cells were exposed to 1 M staurosporine (sts) for
6 h or left untreated and then permeabilized with digitonin. Respiration
was stimulated by the addition of glutamate and malate, of succinate,
or of TMPD, in all cases in the presence of DNP. Rates (averages of 2–4
independent experiments  one standard deviation) are given as per-
centages of rates in untreated permeabilized cells. a, 143B cells; b, B15
cells. Light gray bars, no added cytochrome c; dark gray bars, added
cytochrome c.
FIG. 7. Distribution of cytochrome c (Cyt.c) in digitonin-per-
meabilized 143B cells. Unexposed cells or cells exposed to staurospo-
rine for 4 h were permeabilized, centrifuged onto round glass coverslips,
fixed, and stained with antibodies directed against cytochrome c and
against Hsp60. The panels on the right show the merged images of
green fluorescence (cytochrome c) and red fluorescence (Hsp60).
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with staurosporine for 6 h, from untreated 143B cells, and
likewise, from naive and staurosporine-treated B15 cells. The
surprising results shown in Fig. 8 revealed that the activities of
complex I, complex III, and complex I  III were not signifi-
cantly different between untreated and staurosporine-treated
cells. This important observation, combined with the finding of
complete restoration by cytochrome c of the capacity of digito-
nin-permeabilized staurosporine-treated 143B cells to respire
on exogenous oxidizable substrates, indicated that the early
decline in endogenous respiration in staurosporine-caused
apoptosis was due to an apoptosis-induced outer mitochondrial
membrane permeability change, resulting in a block in respi-
ratory substrate uptake.
DISCUSSION
We have reported here an early and progressive inhibition of
endogenous substrate-dependent respiration in 143B cells dur-
ing the first 6–8 h of treatment with the apoptosis inducer
staurosporine. TMPD-driven (complex IV-dependent) respira-
tion was not significantly affected during the same period. We
have no information on the distribution within the cell popu-
lation of this respiration loss, i.e. whether respiration was
affected partially in every cell or whether a fraction of the cells
had completely lost endogenous substrate-dependent respira-
tion. The latter alternative seems, however, more likely, on the
basis of the available evidence on the intercellular mosaicism of
apoptosis-related phenomena (24, 39). In any case, the data
clearly showed that this loss of respiration in staurosporine-
treated cells preceded the release of cytochrome c from mito-
chondria and the fragmentation of nuclei. Our results differ
from those of Ha´jek et al. (24), who reported that, in anti-Fas
antibody-treated Jurkat cells, the loss of TMPD-dependent and
of endogenous respiration occurred nearly simultaneously and
followed cytochrome c release from mitochondria. This differ-
ence in the sequence of events could be due to the different
pathway taking place in Fas-induced apoptosis.
It should be mentioned that an early decline in endogenous
substrate-dependent respiration, which appeared to be inde-
pendent of cytochrome c release, has also been observed in a rat
cell line of neuronal derivation, PC12, treated with staurospo-
rine.3 In yet another system, Schulze-Osthoff et al. (40) re-
ported a specific decrease in complex I- and complex III-de-
pendent respiration rates in mouse fibrosarcoma cells treated
with tumor necrosis factor-.
A valuable insight into the mechanism underlying the early
decrease in endogenous respiration in staurosporine-treated
cells was provided by the observation that, although respira-
tion measurements in B15 cells suggested that complex I and
complex III activities were decreased, spectrophotometric as-
says of the respective enzyme activities, namely NADH-ubiqui-
none oxidoreductase activity and ubiquinol-cytochrome c oxi-
doreductase activity, showed them to be normal in sonicated
mitochondria from both 143B and B15 cells. We propose that
the basis for this apparent discrepancy in our results is that the
outer mitochondrial membrane, during staurosporine-induced
programmed cell death, becomes impermeable to metabolites
such as glutamate, succinate, and ADP. Consequently, respi-
ration is halted in these cells because of the inability of mito-
chondria to take up oxidizable substrates. Fig. 9 depicts in
schematic form our views of the early changes in mitochondria
that have been detected in our experiments. Thus, we interpret
our finding that, in intact 143B cells, the overall endogenous
substrate-dependent respiration rate was decreased by about
30% in a cell population exposed to staurosporine for 6 h as
indicating that, in 30% of the cells, the outer mitochondrial
membrane was impermeable to substrates.
The interpretation that we propose to explain the apparent
discrepancy between the results of enzyme activity measure-
ments and those of the polarographic measurements has been
fully confirmed by the observation of another unusual phenom-
enon associated with staurosporine-induced apoptosis. As re-
ported previously by Ha´jek et al. (24) for Jurkat cells induced to
undergo apoptosis by anti-Fas antibodies, we found that the
outer mitochondrial membrane in cells undergoing the apo-
ptotic program was disrupted by the digitonin treatment used
to permeabilize cells, in such a way as to allow cytochrome c to
be released from mitochondria (Fig. 9). In our experiments, the
first evidence for this disruption of the outer membrane was
that cytochrome c added back to digitonin-treated 143B cells
stimulated all of the substrate-driven respiration rates. In fact,
mitochondria of staurosporine-treated and digitonin-permeabi-
lized 143B cells exhibited a recovery of100% of the exogenous
substrate- and TMPD-driven respiration rates of digitonin-
permeabilized naive cells, when cytochrome c was provided. In
this situation, the removal of the outer membrane also removed
the barrier to substrate uptake. Therefore, there was no evi-
dence of any defect in complex I- or complex III-dependent
respiration.
The loss of cytochrome c from mitochondria in digitonin-
permeabilized cells was subsequently directly confirmed by
confocal immunofluorescence microscopy as had been done pre-
viously for Jurkat cells treated with anti-Fas antibodies and
digitonin (24). This loss of outer mitochondrial membrane in-
tegrity occurred at a concentration of digitonin that had no
effect on normal mitochondria, indicating that the phenomenon
took place in cells in which the outer mitochondrial membrane
had been “primed” for apoptosis.
At 4 h after the addition of staurosporine, when permeabili-
zation of 143B cells with digitonin led to loss of cytochrome c
from mitochondria in at least 75% of the cells, no other param-
eter of apoptosis progression was positive in such a large pro-
portion of the cell population (Fig. 1). In particular, at 4 h after
staurosporine addition, only 12% of intact cells showed an
extramitochondrial localization of cytochrome c.
3 E. Ferraro and G. Attardi, unpublished data.
FIG. 8. Enzyme activities in mitochondria isolated from stau-
rosporine-treated or untreated 143B cells (a) and B15 cells (b).
Dark gray bars represent data after no staurosporine treatment, and
light gray bars represent data after staurosporine treatment for 6 h at
1 M. Two mitochondria preparations each were made from control and
staurosporine-treated 143B cells, and two preparations each were made
from control and staurosporine-treated B15 cells. Measurements were
made from both preparations for all assays except for complex IV in
143B cells. Activities were first normalized to citrate synthetase (CS)
activity in the mitochondria preparations. The activity for each enzyme
assay (averages of 4–7 measurements (a) or 3–11 measurements (b) 
one standard deviation) is presented as a percentage of the activity in
mitochondria from untreated cells.
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The most likely interpretation of the digitonin hypersensi-
tivity observed in this work is that the outer membrane of
mitochondria underwent, very early in apoptosis, a structural
change. Such a structural change might have involved a change
in lipid composition or distribution that made its integrity
sensitive to 0.005% digitonin. This structural change may be
the “priming” event for apoptosis referred to by Ha´jek et al.
(24). An alternative interpretation of the digitonin effect,
namely that the digitonin permeabilization may have caused
the release of transacting apoptogenic factors from cells more
advanced in the apoptotic program, thereby triggering cyto-
chrome c release from mitochondria in the less advanced cells,
was substantially excluded in the present work by the result of
an experiment we performed in which the digitonin permeabi-
lization was carried out in a highly diluted cell suspension.
An important observation in the present work was that Bcl-
2-overexpressing 143B cells exhibited the same early decrease
in endogenous respiration after staurosporine treatment. This
finding indicated that the change in outer membrane perme-
ability occurred upstream of the step affected by Bcl-2 activity
or in an independent pathway. In Bcl-2-overexpressing cells,
there was no release of cytochrome c from mitochondria, un-
derlining the fact that the decrease in endogenous respiration
is not dependent on cytochrome c release.
In contrast to 143B cells, mitochondria of the B15 Bcl-2-
overexpressing cells exposed to staurosporine for 6 h and per-
meabilized with digitonin exhibited a 40% decrease in the rate
of glutamate/malate-driven respiration, very similar to the
35% decrease in the rate of endogenous respiration observed
in intact cells. These results are consistent with the interpre-
tation that the outer mitochondrial membrane in digitonin-
permeabilized B15 cells is intact, and that in 40% of the cells,
it is refractory to uptake of substrates (Fig. 9). The lack of effect
of added cytochrome c on the respiration rates in digitonin-
permeabilized B15 cells provided further support for this
interpretation.
What is the change in the outer mitochondrial membrane
that occurs early in the program of apoptosis and renders the
membrane refractory to uptake of substrates? The passage of
substrates, other metabolites, and small molecules through the
outer membrane takes place through the VDAC (or porin) (41,
42), an abundant mitochondrial protein. Furthermore, the per-
meability of VDAC is regulatable (43–45). Thus, the closure of
VDAC in a fraction of the cells exposed to staurosporine would
restrict respiration driven by oxidizable substrates, such as
malate and succinate. On the other hand, the entry of TMPD,
which is membrane-permeant, into mitochondria would not be
inhibited by a closed VDAC, and TMPD-driven respiration
would be expected to be unaffected by VDAC closure. Indeed, in
143B and B15 cells treated with staurosporine for 2–6 h, which
exhibited a 20–35% decrease in endogenous respiration rate,
the TMPD-driven respiration rate was found to be the same as
in untreated cells.
Thompson and colleagues (8, 46) have proposed previously
that VDAC closes in apoptosis, on the basis of experiments
showing that the outer mitochondrial membrane becomes less
FIG. 9. Scheme of a model proposed for the interpretation of the experimental results. In 143B intact cells, respiration is sustained by
uptake of ADP and endogenous oxidizable substrates into mitochondria from the cytosol (pink), presumably through VDAC (or porin) (brown).
Digitonin (DIG) permeabilization of naive cells causes endogenous ADP and substrates to diffuse out of the cytosol and allows exogenous ADP and
oxidizable substrates to pass through the plasma membrane (pink) to drive respiration. Staurosporine (STS) treatment causes the permeability
of the outer mitochondrial membrane to ADP and oxidizable substrates to become dramatically curtailed, presumably via VDAC closure.
Staurosporine also causes an alteration in the structure of the outer membrane (shown as a change to green) so that now, digitonin treatment of
staurosporine-treated cells not only permeabilizes the plasma membrane but also disrupts the outer mitochondrial membrane, thereby allowing
cytochrome c (red dot) to leave mitochondria and allowing substrates and ADP to be taken up into the mitochondrial matrix. In the presence of
adequate exogenous cytochrome c and oxidizable substrates, respiration is fully restored. In B15 cells, the outer mitochondrial membrane
permeability change produced by staurosporine occurs as in 143B cells, but digitonin treatment does not cause disruption of the outer membrane,
presumably because this membrane is stabilized by Bcl-2 (in dark blue). Oxidizable substrates and ADP still cannot be taken up by mitochondria.
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permeable to ADP in lymphoblastoid cells that have been de-
prived of growth factor IL-3. Our results are in agreement with
theirs on this point. However, they reported that overexpres-
sion of Bcl-2 or Bcl-XL prevents this decrease in outer mem-
brane permeability, whereas we find that overexpression of
Bcl-2 has no such effect. This discrepancy may be due to dif-
ferences in the level of expression of Bcl-2 or to differences in
the apoptotic pathway in the two systems.
The evidence that VDAC closure, as concerns ADP/ATP ex-
change, occurs in lymphoblastoid cells induced to undergo
apoptosis by interleukin withdrawal (46) provides strong sup-
port for the idea that the early loss of exogenous substrate-
dependent respiration in staurosporine-treated cells represents
another manifestation of VDAC closure. The early decrease in
respiration in a different cell type treated with staurosporine
(PC12)3 and the decrease in complex I- and complex III- de-
pendent respiration rates in a mouse cell line treated with
tumor necrosis factor- (40) may likewise be due to VDAC
closure.
As concerns the question of whether the hypersensitivity to
digitonin detected here in staurosporine-treated cells is related
to apoptosis, the previous evidence of a similar phenomenon in
a completely different apoptotic system (Fas-induced Jurkat
cells) strongly supports the conclusion that this hypersensitiv-
ity is an important indicator of an apoptosis-induced priming of
the outer mitochondrial membrane. On a technical note, the
hypersensitivity to digitonin that we have observed indicates
that caution should be used in interpreting results from exper-
iments in which digitonin has been used to permeabilize or lyse
cells undergoing apoptosis or in the preparation of a mitochon-
drial fraction from such cells.
In summary, we have provided evidence that points to
changes in the outer mitochondrial membrane that occur very
early in the apoptotic program. A comparison of the data in
Figs. 1 and 5a gives an idea of the order of these changes
relative to the hallmark events of apoptosis. After 4 h of expo-
sure of 143B cells to staurosporine, the outer mitochondrial
membrane in at least 75% of the cells has undergone a change
in structure that makes it hypersensitive to digitonin (Fig. 5a).
At the same time, endogenous substrate-dependent respiration
has decreased by 20–25%, 12% of the cells have released cyto-
chrome c from mitochondria, and fewer than 10% of the cells
have progressed to the stage of having fragmented nuclei (Fig.
1). These data suggest the following sequence. Very early, after
the apoptotic stimulus, the outer membrane of mitochondria
undergoes a structural change, becoming primed for apoptosis.
This change is detectable so far only in vitro, as a hypersensi-
tivity to digitonin. Next, the outer membrane becomes imper-
meable to oxidizable substrates and ADP, presumably because
VDAC closes. This step is followed by cytochrome c release from
mitochondria, and lastly, by nuclear degradation. It seems
likely that staurosporine-treated cells that have released cyto-
chrome c from mitochondria represent a subgroup of those in
which the outer membrane permeability has been altered (pre-
sumably those in which the effect of VDAC closure are more
advanced). Vander Heiden et al. (46) have suggested that
VDAC closure in lymphoblastoid cells deprived of IL-3 leads to
hyperpolarization of the mitochondrial inner membrane, swell-
ing of the matrix, and consequent rupture of the outer mem-
brane and release of cytochrome c. Further work is needed to
clarify which effects of VDAC closure in staurosporine-treated
cells may be crucial for the release from mitochondria of apo-
ptogenic molecules, in particular, of cytochrome c.
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